Ugo Pradère

945 total citations · 1 hit paper
13 papers, 767 citations indexed

About

Ugo Pradère is a scholar working on Infectious Diseases, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Ugo Pradère has authored 13 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Ugo Pradère's work include HIV/AIDS drug development and treatment (10 papers), Biochemical and Molecular Research (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Ugo Pradère is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), Biochemical and Molecular Research (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Ugo Pradère collaborates with scholars based in France, United States and Belgium. Ugo Pradère's co-authors include Raymond F. Schinazi, Steven J. Coats, Franck Amblard, Ethel C. Garnier‐Amblard, Vincent Roy, Luigi A. Agrofoglio, Tamara R. McBrayer, Steven P. Nolan, Robert Snoeck and Graciela Andreï and has published in prestigious journals such as Chemical Reviews, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Ugo Pradère

13 papers receiving 759 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs

2014 484 citations Ugo Pradère, Ethel C. Garnier‐Amblard et al. Chemical Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ugo Pradère France	11	447	389	294	113	72	13	767
Mao‐Chin Liu United States	14	288 0.6×	380 1.0×	350 1.2×	183 1.6×	36 0.5×	33	743
Petr Nauš Czechia	14	367 0.8×	319 0.8×	250 0.9×	131 1.2×	15 0.2×	21	696
Steven J. Coats United States	19	791 1.8×	586 1.5×	477 1.6×	239 2.1×	116 1.6×	64	1.5k
Anne M. Exall United Kingdom	16	403 0.9×	352 0.9×	184 0.6×	106 0.9×	15 0.2×	22	662
Michael R. Harnden United States	13	423 0.9×	296 0.8×	236 0.8×	175 1.5×	31 0.4×	34	706
Christophe Mathé France	16	424 0.9×	578 1.5×	507 1.7×	203 1.8×	23 0.3×	71	1.1k
Elisabetta Groaz Belgium	14	263 0.6×	403 1.0×	116 0.4×	74 0.7×	58 0.8×	52	606
Tokumi Maruyama Japan	15	356 0.8×	424 1.1×	198 0.7×	126 1.1×	8 0.1×	79	713
Bärbel Bennua Germany	5	615 1.4×	673 1.7×	318 1.1×	114 1.0×	21 0.3×	7	1.0k
Sena Garber United States	17	431 1.0×	340 0.9×	563 1.9×	91 0.8×	65 0.9×	23	1.1k

Countries citing papers authored by Ugo Pradère

Since Specialization

Citations

This map shows the geographic impact of Ugo Pradère's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ugo Pradère with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ugo Pradère more than expected).

Fields of papers citing papers by Ugo Pradère

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ugo Pradère. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ugo Pradère. The network helps show where Ugo Pradère may publish in the future.

Co-authorship network of co-authors of Ugo Pradère

This figure shows the co-authorship network connecting the top 25 collaborators of Ugo Pradère. A scholar is included among the top collaborators of Ugo Pradère based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ugo Pradère. Ugo Pradère is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Zhou, Longhu, Hongwang Zhang, Sijia Tao, et al.. (2015). β-d-2′-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5′-Triphosphate Forms. Journal of Medicinal Chemistry. 58(8). 3445–3458. 31 indexed citations

Pradère, Ugo, Ethel C. Garnier‐Amblard, Steven J. Coats, Franck Amblard, & Raymond F. Schinazi. (2014). Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs. Chemical Reviews. 114(18). 9154–9218. 484 indexed citations breakdown →

Pradère, Ugo, Peng Liu, Chengwei Li, et al.. (2013). Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(23). 6325–6330. 17 indexed citations

Pradère, Ugo, Vincent Roy, Jan Balzarini, et al.. (2012). Synthesis and antiviral evaluation of bis(POM) prodrugs of (E)-[4′-phosphono-but-2′-en-1′-yl]purine nucleosides. European Journal of Medicinal Chemistry. 57. 126–133. 13 indexed citations

Sohl, Christal D., Rajesh Kasiviswanathan, Ugo Pradère, et al.. (2012). Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase. Molecular Pharmacology. 82(1). 125–133. 15 indexed citations

Pradère, Ugo, Franck Amblard, Steven J. Coats, & Raymond F. Schinazi. (2012). Synthesis of 5′-Methylene-Phosphonate Furanonucleoside Prodrugs: Application to D-2′-Deoxy-2′-α-fluoro-2′-β-C-methyl Nucleosides. Organic Letters. 14(17). 4426–4429. 13 indexed citations

Pradère, Ugo, Hervé Clavier, Vincent Roy, Steven P. Nolan, & Luigi A. Agrofoglio. (2011). The Shortest Strategy for Generating Phosphonate Prodrugs by Olefin Cross‐Metathesis – Application to Acyclonucleoside Phosphonates. European Journal of Organic Chemistry. 2011(36). 7324–7330. 15 indexed citations

Pradère, Ugo, et al.. (2011). Expeditious convergent procedure for the preparation of bis(POC) prodrugs of new (E)-4-phosphono-but-2-en-1-yl nucleosides. Tetrahedron. 67(29). 5319–5328. 26 indexed citations

Roy, Vincent, Ugo Pradère, & Luigi A. Agrofoglio. (2010). Microwave-Assisted Syntheses of Nucleosides and Their Precursors. Future Medicinal Chemistry. 2(2). 177–192. 7 indexed citations

10.

Topalis, Dimitri, Ugo Pradère, Vincent Roy, et al.. (2010). Novel Antiviral C5-Substituted Pyrimidine Acyclic Nucleoside Phosphonates Selected as Human Thymidylate Kinase Substrates. Journal of Medicinal Chemistry. 54(1). 222–232. 45 indexed citations

11.

Kumamoto, Hiroki, Dimitri Topalis, Julie Broggi, et al.. (2008). Preparation of acyclo nucleoside phosphonate analogues based on cross-metathesis. Tetrahedron. 64(16). 3517–3526. 34 indexed citations

12.

Pradère, Ugo, Vincent Roy, Tamara R. McBrayer, Raymond F. Schinazi, & Luigi A. Agrofoglio. (2008). Preparation of ribavirin analogues by copper- and ruthenium-catalyzed azide-alkyne 1,3-dipolar cycloaddition. Tetrahedron. 64(38). 9044–9051. 66 indexed citations

13.

Topalis, Dimitri, Julie Broggi, Ugo Pradère, et al.. (2008). Evaluation of C-5 Substituted Uracil Acyclic Phosphonates as Substrates or Inhibitors for DTMP and UMP–CMP Kinases and Potential Antipox Derivatives. Antiviral Research. 78(2). A65–A65. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact